With a growing Phase III pipeline, and an even larger Phase II pipeline, commercialized gene therapies are poised to expand, bringing with them manufacturing challenges that the industry is working to address.
Explore some of the challenges of manufacturing as they relate to gene therapy, including the increased need for viral vectors to deliver genes into target cells, and issue of a CMO shortage, as few CMO players currently have the capability to work in this highly-specialized area.
Explore some of the challenges of manufacturing as they relate to gene therapy, including the increased need for viral vectors to deliver genes into target cells, and issue of a CMO shortage, as few CMO players currently have the capability to work in this highly-specialized area.
